Glenmark Life Sciences Ltd
NSE:GLS
Glenmark Life Sciences Ltd
Depreciation & Amortization
Glenmark Life Sciences Ltd
Depreciation & Amortization Peer Comparison
Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors
Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
G
|
Glenmark Life Sciences Ltd
NSE:GLS
|
Depreciation & Amortization
-₹534.5m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-50%
|
CAGR 10-Years
N/A
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Depreciation & Amortization
-₹14.7B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
Cipla Ltd
NSE:CIPLA
|
Depreciation & Amortization
-₹10.5B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-11%
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Depreciation & Amortization
-₹25.8B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-21%
|
|
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
|
Depreciation & Amortization
-₹7.4B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-14%
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Depreciation & Amortization
-₹8B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-25%
|
See Also
What is Glenmark Life Sciences Ltd's Depreciation & Amortization?
Depreciation & Amortization
-534.5m
INR
Based on the financial report for Mar 31, 2024, Glenmark Life Sciences Ltd's Depreciation & Amortization amounts to -534.5m INR.
What is Glenmark Life Sciences Ltd's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 5Y
-50%
Over the last year, the Depreciation & Amortization growth was -27%. The average annual Depreciation & Amortization growth rates for Glenmark Life Sciences Ltd have been -17% over the past three years , -50% over the past five years .